BRINTELLIX 5 mg, film-coated tablet 56 tablets
Active ingredients: Vortioxetine hydrobromide, Vortioxetine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRINTELLIX 5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 56 plaquette(s) thermoformée(s) PVC PVDC aluminium de 1 comprimé(s)
- Marketing authorisation holder
- LUNDBECK (DANEMARK)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Oct 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62792157CIP75508301CIP133400955083016Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VORTIOXÉTINEcomprimé | 5 mg · un comprimé | FT |
| BROMHYDRATE DE VORTIOXÉTINEcomprimé | 6,355 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.